Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Safety and efficacy of talquetamab in patients with relapsed and refractory multiple myeloma (RRMM) with and without renal impairment (RI)

Blood (2025) 146 (Supplement 1): 827.

https://doi.org/10.1182/blood-2025-827

Published: 2025

Journal Articles

Real world outcomes of bispecific T-cell engagers in plasma cell leukemia

Blood (2025) 146 (Supplement 1): 823.

https://doi.org/10.1182/blood-2025-823

Published: 2025

Journal Articles

Two decades of infectious mortality in Myelodysplastic Syndromes: An analysis from the CDC wonder database

Muhammad Waseem Tahir, Diljot Singh, Zubia Tahir, Saira Chaughtai, Abigail Emerson, Aman Ullah, Ranju Kunwor, Sherif Eltawansy, Ali Bhatti, FNU Veena, Muhammad Bilal, Zaheer Qureshi, Moazzam Shahzad, Jawad Ahmed, Fouad Hocine, Karm Khalid

Blood (2025) 146 (Supplement 1): 6414.

https://doi.org/10.1182/blood-2025-6414

Published: 2025

Journal Articles

Daratumumab, bortezomib, lenalidomide and dexamethasone, upfront autologous transplant and lenalidomide maintenance for newly diagnosed multiple myeloma

Blood (2025) 146 (Supplement 1): 7509.

https://doi.org/10.1182/blood-2025-7509

Published: 2025

Journal Articles

Racial, geographic, and gender disparities in ischemic heart disease mortality in patients with multiple myeloma: A nationwide analysis (1999–2023).

Muhammad Waseem Tahir, Zubia Tahir, Abigail Emerson, Saira Chaughtai, Sherif Eltawansy, Ranju Kunwor, Muhammad Bilal, Aman Ullah, Ali Bhatti, Diljot Singh, Zaheer Qureshi, Moazzam Shahzad, Fatima Khurram, Fouad Hocine, Ali Usama

Blood (2025) 146 (Supplement 1): 8114.

https://doi.org/10.1182/blood-2025-8114

Published: 2025

Journal Articles

Characterizing differences in CAR-T cell therapy outcomes based on sex in patients with large B-cell lymphoma

John Behman, Muhammad Bilal Abid

Blood (2025) 146 (Supplement 1): 1948.

https://doi.org/10.1182/blood-2025-1948

Published: 2025

Journal Articles

Trends and disparities in infection-related mortality among non-Hodgkin lymphoma patients in the United States, 1999–2023

Muhammad Waseem Tahir, Zubia Tahir, Abigail Emerson, Saira Chaughtai, Ranju Kunwor, Aman Ullah, Muhammad Bilal, Zaheer Qureshi, Ali Bhatti, Diljot Singh, Moazzam Shahzad, Salman Fazal, FNU Veena, Sherif Eltawansy, Muneeba Syed, Junaid Saleem

Blood (2025) 146 (Supplement 1): 8046.

https://doi.org/10.1182/blood-2025-8046

Published: 2025

Journal Articles

Impact of putative cell of origin on CD19+CAR-T outcomes in patients with large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 5500.

https://doi.org/10.1182/blood-2025-5500

Published: 2025

Journal Articles

Impact of venous thromboembolism on clinical outcomes in patients with brain cancer: A national inpatient sample analysis from 2018-2020

Jawad Ahmed, Muhammad Umer Sohail, Anoud Khan, Furqan Hassan, Hanzala Jehangir, Fatima Aslam, Ayena Mujtaba, Muhammad Bilal Hashmat, Aminah Tayyab, Dua Jabeen, Muhammad Hashir Khan, Shahzaib Khan

Blood (2025) 146 (Supplement 1): 4912.

https://doi.org/10.1182/blood-2025-4912

Published: 2025

Journal Articles

Reversal of declining cardiac mortality trends in hemolytic anemia: National evidence from 1999 to 2023

Muhammad Waseem Tahir, Zubia Tahir, Abigail Emerson, Saira Chaughtai, Ranju Kunwor, Aman Ullah, Muhammad Bilal, Ali Bhatti, Diljot Singh, Sherif Eltawansy, Zaheer Qureshi, Moazzam Shahzad, Fouad Hocine, FNU Veena, Karm Khalid

Blood (2025) 146 (Supplement 1): 7899.

https://doi.org/10.1182/blood-2025-7899

Published: 2025

Journal Articles

Infections in patients with relapsed refractory multiple myeloma receiving idecabtagene vicleucel therapy: A real-world analysis from CIBMTR

Muhammad Bilal Abid, Kitsada Wudhikarn, Qiran Ye, Michael Martens, Abu-Sayeef Mirza, Lohith Gowda, Srinivas Devarakonda, Yvonne Efebera, Zeinab El Boghdadly, Christopher Dandoy, Othman Akhtar, Temitope Oloyede, Christen Ebens, Joshua Hill, Hemant Murthy, Miguel-Angel Perales, Anna Huppler, Jeffery Auletta

Blood (2025) 146 (Supplement 1): 716.

https://doi.org/10.1182/blood-2025-716

Published: 2025

Journal Articles

Cost-conscious CAR T delivery: Outpatient (OP) cilta-cel administration reduces health care resource utilization (HCRU) and the associated post-infusion cost

Christopher Ferreri, Mahmoud Gaballa, Minifrida Santiago, Michelly Abreu, Muhammad Bilal Abid, Michelle Hildebrandt, Misha Hawkins, Jessica Chen, Lynzi Funk, Brandon Crumpton, Cindy Varga, Shebli Atrash, Krina Patel

Blood (2025) 146 (Supplement 1): 2634.

https://doi.org/10.1182/blood-2025-2634

Published: 2025

Journal Articles

Trends and Disparities in Autoimmune Hemolytic Anemia-Related Mortality in the United States from 1999 to 2020: Insights from the CDC Wonder Database

Moazzam Shahzad, Eeman Ahmad, Shahzaib Ahmed, Umar Akram, Muhammad Bilal Sardar, Fatima Tuz Zahra, Qamar Iqbal, Muhammad Umair Mushtaq, Michael V. Jaglal

Blood (2024) 144 (Supplement 1): 5232.

https://doi.org/10.1182/blood-2024-209176

Published: 2024

Journal Articles

Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity

Blood (2024) 143 (26): 2722–2734.

https://doi.org/10.1182/blood.2023023447

Published: 2024

Includes: Supplemental data

Journal Articles

Recent Trends in the Prevalence of Antibiotic-Resistant Organism Infections (AROI) in Acute Leukemia Patients

Vedavyas Gannamani, Vaishali Deenadayalan, Sravya Manne, Srilatha Vinumurthy, Jay Vakil, Maria Cuartas, Muhammad Bilal Ibrahim, Maryam Zia

Blood (2023) 142 (Supplement 1): 7444.

https://doi.org/10.1182/blood-2023-188260

Published: 2023

Journal Articles

Comparison of Allogeneic Hematopoietic Cell Transplantation Outcomes from Younger Matched Unrelated Donor Versus Older Sibling Donor for Acute Myeloid Leukemia

Muhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, Karen Chen, David S. Allan, Christopher Bredeson, Mitchell Sabloff, Mark R. Litzow, Partow Kebriaei, Wael Saber

Blood (2022) 140 (Supplement 1): 909–910.

https://doi.org/10.1182/blood-2022-162742

Published: 2022

Journal Articles

Younger Matched Unrelated Donors Confer a Decreased Relapse Risk As Compared to Older Sibling Donors for Adult B-Cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Muhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, Karen Chen, Christopher Bredeson, David S. Allan, Mitchell Sabloff, Mark R. Litzow, Partow Kebriaei, Wael Saber

Blood (2022) 140 (Supplement 1): 10540–10541.

https://doi.org/10.1182/blood-2022-163517

Published: 2022

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Blood (2021) 138 (Supplement 1): 3880.

https://doi.org/10.1182/blood-2021-148652

Published: 2021

Journal Articles

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Blood (2021) 137 (23): 3291–3305.

https://doi.org/10.1182/blood.2020009362

Published: 2021

Includes: Supplemental data

Journal Articles

Cystic splenomegaly: ectopic adenocarcinoma of unknown primary

Muhammad Bilal Abid, Norbert Blesing

Blood (2017) 129 (26): 3502.

https://doi.org/10.1182/blood-2017-03-773713

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Safety and efficacy of talquetamab in patients with relapsed and refractory multiple myeloma (RRMM) with and without renal impairment (RI)

Real world outcomes of bispecific T-cell engagers in plasma cell leukemia

Two decades of infectious mortality in Myelodysplastic Syndromes: An analysis from the CDC wonder database

Daratumumab, bortezomib, lenalidomide and dexamethasone, upfront autologous transplant and lenalidomide maintenance for newly diagnosed multiple myeloma

Racial, geographic, and gender disparities in ischemic heart disease mortality in patients with multiple myeloma: A nationwide analysis (1999–2023).

Characterizing differences in CAR-T cell therapy outcomes based on sex in patients with large B-cell lymphoma

Trends and disparities in infection-related mortality among non-Hodgkin lymphoma patients in the United States, 1999–2023

Impact of putative cell of origin on CD19+CAR-T outcomes in patients with large B-cell lymphoma

Impact of venous thromboembolism on clinical outcomes in patients with brain cancer: A national inpatient sample analysis from 2018-2020

Reversal of declining cardiac mortality trends in hemolytic anemia: National evidence from 1999 to 2023

Infections in patients with relapsed refractory multiple myeloma receiving idecabtagene vicleucel therapy: A real-world analysis from CIBMTR

Cost-conscious CAR T delivery: Outpatient (OP) cilta-cel administration reduces health care resource utilization (HCRU) and the associated post-infusion cost

Trends and Disparities in Autoimmune Hemolytic Anemia-Related Mortality in the United States from 1999 to 2020: Insights from the CDC Wonder Database

Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity

Recent Trends in the Prevalence of Antibiotic-Resistant Organism Infections (AROI) in Acute Leukemia Patients

Comparison of Allogeneic Hematopoietic Cell Transplantation Outcomes from Younger Matched Unrelated Donor Versus Older Sibling Donor for Acute Myeloid Leukemia

Younger Matched Unrelated Donors Confer a Decreased Relapse Risk As Compared to Older Sibling Donors for Adult B-Cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Cystic splenomegaly: ectopic adenocarcinoma of unknown primary

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only